Amikacin Fresenius Kabi

Amikacin Fresenius Kabi is an intravenous antibiotic used to treat serious bacterial infections. This medication is part of the aminoglycoside class and is manufactured by Fresenius Kabi S.R.O. in the EU.

Amikacin is primarily used to treat severe bacterial infections, including those caused by gram-negative bacteria. It is often prescribed when other antibiotics are ineffective. Amikacin is administered intravenously and is used for conditions such as sepsis, pneumonia, and urinary tract infections.

Common effects of Amikacin may include kidney problems, hearing loss, and balance issues. These effects are more likely to occur with prolonged use or high doses. Patients should be monitored for signs of toxicity.

Amikacin should be used with caution in patients with kidney disease or hearing problems. Regular monitoring of kidney function and hearing is recommended during treatment. It is important to follow the prescribed dosage and administration schedule.

Amikacin may interact with other medications, including certain diuretics, other aminoglycosides, and medications that affect kidney function. Alcohol and other substances that affect the kidneys should be avoided during treatment.